A toxic protein fragment found in the deadly Ebola virus has been identified by researchers at the Louisiana State University’s New Orleans Medical School.
The fragment is poisonous to many types of cells, and may play a significant role in both infection and subsequent illness, although its precise function has yet to be established. Read the rest of this entry »
A new study has found a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it.
Using targeted biological therapy can improve the outcome for cancer patients, while reducing the toxicity of the treatment, when compared to the adverse effects of standard chemotherapeutic drugs. Read the rest of this entry »
A new test developed by researchers at the Royal Infirmary of Edinburgh could save thousands of women at risk of suffering a heart attack.
The more sensitive blood test is able to detect even minute levels of a key protein linked to damage of the heart muscles – troponin. Read the rest of this entry »
A new study, published in the Journal of the American Society of Nephrology (JASN), has proven links between certain genetic variants and kidney disease.
According to the team, this is one of the strongest associations ever reported for common disease. It is hoped that this finding could help diagnosis and treatment. Read the rest of this entry »
A new study, published in Molecular Cancer Research, has discovered a signalling pathway that is key in generating slowly proliferating cancer cells.
This finding could be highly relevant as it is these cancer cells that are hard to target with current treatments and are thought to be a cause of subsequent disease relapse.
"We have identified a new pathway in which well-studied signalling molecules string together to regulate cell proliferation," said Sridhar Ramaswamy, an associate professor of medicine at Massachusetts General Hospital Cancer Center and Harvard Medical School in Boston. Read the rest of this entry »